Welcome to our dedicated page for Encision SEC filings (Ticker: ECIA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Encision Inc. filings document the company’s Exchange Act reporting status, common-stock registration matters, and material corporate events. The Form 15-12G records Encision’s certification and notice to terminate registration under Section 12(g) and suspend reporting duties for its common stock.
Recent Form 8-K disclosures cover the company’s plan to deregister, its OTC-traded common stock, board and executive changes, and related exhibit filings. The filing record also identifies Encision as a Colorado issuer with common stock, no par value, under the ECIA trading symbol.
Encision Inc. director equity grant: Director Brandon Shepard reported receiving a stock option award from Encision Inc. (ticker ECIA) on 11/18/2025. The option gives him the right to buy 10,000 shares of Encision common stock at an exercise price of $0.25 per share.
The option expires on 02/17/2031. The grant vests over time, with 33% vesting after the first year of service on 11/18/2026 and the remaining portion vesting in 36 equal installments thereafter. Following this transaction, Shepard beneficially owns 10,000 derivative securities directly.
Encision Inc. (ECIA) reported a new equity award to an executive. Vice President of Marketing Brandon Shepard received an option on 10,000 shares of Encision common stock on 11/18/2025 at an exercise price of $0.25 per share. The option expires on 02/17/2031. The award vests 20% after one year of service on 11/18/2026, with the remaining shares vesting in 48 equal installments thereafter, so the grant becomes exercisable gradually over time while he remains in service.
Encision Inc. (ECIA) reported a weaker quarter for the three months ended September 30, 2025. Total revenue was $1.53 million, down from $1.76 million a year ago, as product sales fell 10% to $1.48 million and service revenue decreased to $46,248 following a brief project suspension by a customer. Gross margin was 46% versus 47% a year earlier. The company posted a net loss of $267,833, compared with a $170,262 loss last year.
Cash declined to $71,731 from $257,433 at March 31, 2025. Working capital was $1.38 million, and current borrowings under the line of credit were $31,706 with up to $968,294 available, subject to eligible receivables. Management states there is substantial doubt about continuing as a going concern without additional financing, though a private placement on August 19, 2025 added $500,000 and increased shares outstanding to 16,879,645.
The quarter also reflected lower sales and marketing and G&A costs, offset by higher R&D. Disclosure controls were deemed not effective due to inadequate segregation of duties.
Encision, Inc. disclosed a board change. Director Patrick Pace resigned on October 30, 2025. The company stated the resignation was not the result of any dispute or disagreement regarding its operations, policies, or practices.
The filing records the change under Item 5.02 and was signed by Controller and Principal Accounting Officer Brandon Shepard.